NSE: COLPAL · BSE: 500830
COLGATE PALMOLIVE LTD.
Makes and sells oral care and personal care products in India under the Colgate brand. The portfolio spans core and premium toothpaste (Colgate Total, Visible White Purple, Max Fresh, Strong Teeth), toothbrushes and adjacent personal care lines, sold to Indian consumers through general trade, modern retail and e-commerce, with e-commerce at about 10% of the business. Q4 FY26 net sales were Rs 1,583 crore, up 9% year-on-year on domestic growth of 9.2%, and Q1 FY27 rose 12% to Rs 1,591 crore; full-year FY26 revenue was Rs 5,984 crore. The premium portfolio mix has grown 35% over two years, with premium brands growing 6x faster than the overall toothpaste category and whitening products growing 4x faster. It runs an oral-health programme with QR codes on 500 million packs, generating 4.5 million scans and about 1 million free dentist consultations, in partnership with 50,000+ dentists, and a B2B dental-professional channel served by a 150+ field force that grew 50-60% over two years. The company operates four plants (all TRUE Platinum zero-waste certified) with 875 permanent employees and 1,401 permanent workers. The biggest input costs are raw materials at 25.5% of revenue and other operating expense at 30.7%, with advertising spend stepped up 10% in Q4 to about Rs 200 crore; FY26 EBITDA margin was 32%. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Oral care (toothpaste and toothbrushes), Personal care, B2B dental-professional channel. Brand-led, asset-light FMCG with high gross margins (~69%) and a premiumization skew in oral care.
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · standalone | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 5,100 | 5,226 | 5,680 | 6,040 | 6,035 |
| EBITDA (ex other income) | 1,566 | 1,536 | 1,881 | 1,958 | 1,845 |
| margin % | 30.7 | 29.4 | 33.1 | 32.4 | 30.6 |
| Owners' profit | 1,078 | 1,047 | 1,324 | 1,437 | 1,325 |
| EPS, as reported (₹) | 39.65 | 38.50 | 48.67 | 52.83 | 48.73 |
| ROE % · ROCE % | 62.2 · 77.8 | 61.0 · 78.7 | 70.6 · 91.3 | 86.3 · 111.1 | 83.7 · 107.4 |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from operations | 1,626 | 1,176 | 1,199 | 1,394 | 1,806 |
| Capex | (50) | (70) | (76) | (71) | (76) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,619 | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 | 1,595 | 1,603 |
| Profit before tax | 530 | 433 | 478 | 432 | 442 | 436 | 474 | 462 |
| Net profit | 395 | 323 | 355 | 321 | 328 | 324 | 353 | 343 |
| EPS (₹) | 14.52 | 11.87 | 13.05 | 11.79 | 12.04 | 11.91 | 12.99 | 12.61 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| GODREJ CONSUMER PRODUCTS | 84,803 | 44.3 | 6.70 | 27.6 | 14.7 | 19.0 | 6.6 | 19.8 |
| DABUR INDIA LTD | 63,474 | 32.2 | 5.38 | 21.2 | 15.8 | 19.8 | 6.6 | 24.3 |
| COLGATE PALMOLIVE LTD. ◆ | 43,612 | 32.4 | 27.53 | — | 83.7 | 107.1 | — | 31.3 |
| CUPID LIMITED | 42,491 | 116.2 | 94.26 | 281.8 | 24.0 | 30.3 | — | 40.3 |
| GILLETTE INDIA LTD | 23,823 | 35.7 | 25.17 | — | 69.1 | 83.4 | — | 29.8 |
| P&G HYGIENE & HEALTH CARE | 22,102 | 27.9 | 29.33 | — | 113.7 | 134.4 | — | 20.1 |
| EMAMI LIMITED | 16,061 | 21.4 | 5.50 | 15.4 | 26.5 | 28.4 | 5.6 | 23.5 |
| HONASA CONSUMER LIMITED | 14,621 | 50.4 | 10.36 | 46.0 | 14.2 | 16.9 | — | 17.6 |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 32.4 | 35.7 | 7 of 15 | 57% |
| P/B | 27.5 | 6.7 | 11 of 13 | 17% |
| ROCE | 107.1 | 19.4 | 2 of 16 | 93% |
| ROE | 83.7 | 15.8 | 2 of 13 | 92% |
| Debt / Equity | 0.0 | 0.0 | 1 of 13 | 50% |
| EBITDA margin | 31.3 | 23.5 | 2 of 13 | 92% |
| Revenue growth | 11.8 | 13.4 | 8 of 14 | 46% |
| Profit growth | 7.0 | 9.4 | 8 of 13 | 42% |
| Market cap | 43612 | 9835 | 3 of 16 | 87% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 23 Oct 2026 · Rs 24 first interim dividend declared; tax deduction details shared | corporate actions | high | — | — |
| 23 Oct 2026 · Colgate India posts 12.2% sales growth, declares Rs 24 interim dividend | compliance | minimal | — | — |
| 23 Oct 2026 · Q2 revenue rises 12% and net profit rises 4% year on year | compliance | minimal | — | — |
| 22 Oct 2026 · Colgate Palmolive Q2 results, Rs 24 interim dividend, record date Nov 2 | corporate actions | high | — | — |
| 22 Oct 2026 · Rs 24 interim dividend declared after 12.2% sales growth | corporate actions | high | — | — |
| 22 Oct 2026 · Colgate Q2 PAT up; declares Rs 24 interim dividend | corporate actions | high | — | — |
| 22 Oct 2026 · Colgate Q2 net sales up 12.2%, declares Rs. 24 interim dividend | corporate actions | high | — | — |
| 22 Oct 2026 · Q2 growth, Rs 24 dividend, internal auditor and marketing changes | management changes | high | — | — |
| 22 Oct 2026 · Colgate Q2 FY27: 12.2 percent sales growth, Rs 24 interim dividend | results | high | — | — |
| 22 Oct 2026 · Colgate Palmolive Q2 FY27: Net Sales up 12.2%, Rs 24 interim dividend | results | high | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.